1. Immunology/Inflammation Metabolic Enzyme/Protease
  2. STING Endogenous Metabolite
  3. Cyclic-di-GMP diammonium

Cyclic-di-GMP diammonium  (Synonyms: c-di-GMP diammonium; cyclic diguanylate diammonium; 5GP-5GP diammonium)

目录号: HY-107780B 纯度: 99.72%
COA 产品使用指南

Cyclic-di-GMP diammonium 是一种 STING 激动剂,也是细菌第二信使,协调细菌生长和行为的不同方面,包括运动能力、毒力、生物膜的形成和细胞周期的进展。Cyclic-di-GMP diammonium 具有抗癌细胞增殖活性,还可诱导 CD4 受体表达升高和细胞周期停滞。Cyclic-di-GMP diammonium 可用于癌症的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Cyclic-di-GMP diammonium Chemical Structure

Cyclic-di-GMP diammonium Chemical Structure

CAS No. : 609343-82-0

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
1 mg ¥2500
In-stock
5 mg ¥4500
In-stock
10 mg ¥6200
In-stock
50 mg   询价  
100 mg   询价  

* Please select Quantity before adding items.

Customer Review

Other Forms of Cyclic-di-GMP diammonium:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Cyclic-di-GMP diammonium is a STING agonist and a bacterial second messenger that coordinates different aspects of bacterial growth and behavior, including motility, virulence, biofilm formation, and cell cycle progression. Cyclic-di-GMP diammonium has anti-cancer cell proliferation activity and also induces elevated CD4 receptor expression and cell cycle arrest. Cyclic-di-GMP diammonium can be used in cancer research[1][2][3][4].

IC50 & Target
体外研究
(In Vitro)

Cyclic-di-GMP diammonium (0.5-50 μM;5 days) 抑制人结肠癌细胞增殖[1]
Cyclic-di-GMP diammonium (0.5-50 μM;5天) 特异性提高 Jurkat 细胞中的 CD4 表达[2]
Cyclic-di-GMP diammonium (0.5-50 μM;5 天) 诱导 Jurkat 细胞周期停滞在 S 期细胞[2]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay[1]

Cell Line: H508 cells
Concentration: 0.5-50 µM
Incubation Time: 5 days
Result: Reduced basal H508 cell proliferation by approx 15%, even inhibited acetylcholine- and EGF-induced cell proliferation.

Cell Viability Assay[2]

Cell Line: Jurkat cells
Concentration: 50 µM
Incubation Time: 24 h
Result: Specifically induced of CD4 (no effect on the expression of CD8), with a 6.3-fold upregulation over control and in a dose-dependent manner.

Cell Cycle Analysis[2]

Cell Line: Jurkat cells
Concentration: 50 µM
Incubation Time: 24 h
Result: Increased the percentage of cells in S-phase by 79%, with almost complete disappearance of G2/M-phase cells which decreased by 93%.
体内研究
(In Vivo)

Cyclic-di-GMP diammonium (100 μg/次;静脉注射;间隔 9 天的两次连续疫苗接种) 增强 TriVax 诱导的小鼠对黑色素瘤的免疫反应,并进一步增强 TriVax 的抗肿瘤作用[3]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 (B6) mice (8- to 10-week-old)[3].
Dosage: 100 µg/per
Administration: Intravenous injection; two sequential vaccinations 9 days apart; combine with TriVax.
Result: Significantly higher numbers of antigen-specific CD8 T cells when combined with TriVax. (TriVax consisted of a mixture of 120 μg Pam-hgp100, 100 µg hgp100 or 100 µg Ova, 50 or 25 μg anti-CD40 antibody, and 25 μg Poly-IC).
Enhanced the anti-tumor activity of TriVax.
分子量

724.47

Formula

C20H30N12O14P2

CAS 号
性状

固体

颜色

White to off-white

结构分类
初始来源
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

-20°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

溶解性数据
In Vitro: 

H2O 中的溶解度 : 50 mg/mL (69.02 mM; 超声助溶)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 1.3803 mL 6.9016 mL 13.8032 mL
5 mM 0.2761 mL 1.3803 mL 2.7606 mL
查看完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

* 备注:如您选择水作为储备液,请稀释至工作液后,再用 0.22 μm 的滤膜过滤除菌后使用。

  • 摩尔计算器

  • 稀释计算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量
=
浓度
×
体积
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start)

C1

×
体积 (start)

V1

=
浓度 (final)

C2

×
体积 (final)

V2

In Vivo:

以下溶解方案,请直接配置工作液。建议现用现配,在短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在您配制终溶液中的体积占比; 如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶。

  • 方案 一

    请依序添加每种溶剂: PBS

    Solubility: 100 mg/mL (138.03 mM); 澄清溶液; 超声助溶

动物溶解方案计算器
请输入动物实验的基本信息:

给药剂量

mg/kg

动物的平均体重

g

每只动物的给药体积

μL

动物数量

由于实验过程有损耗,建议您多配一只动物的量
计算结果
工作液所需浓度 : mg/mL
该产品水溶性佳,请具体参考实测 水 / PBS / Saline 中的溶解度数据。
您所需的储备液浓度超过该产品的实测溶解度,如有需要,请与 MCE 中国技术支持联系。
纯度 & 产品资料

纯度: 99.72%

参考文献

完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
H2O 1 mM 1.3803 mL 6.9016 mL 13.8032 mL 34.5080 mL
5 mM 0.2761 mL 1.3803 mL 2.7606 mL 6.9016 mL
10 mM 0.1380 mL 0.6902 mL 1.3803 mL 3.4508 mL
15 mM 0.0920 mL 0.4601 mL 0.9202 mL 2.3005 mL
20 mM 0.0690 mL 0.3451 mL 0.6902 mL 1.7254 mL
25 mM 0.0552 mL 0.2761 mL 0.5521 mL 1.3803 mL
30 mM 0.0460 mL 0.2301 mL 0.4601 mL 1.1503 mL
40 mM 0.0345 mL 0.1725 mL 0.3451 mL 0.8627 mL
50 mM 0.0276 mL 0.1380 mL 0.2761 mL 0.6902 mL
60 mM 0.0230 mL 0.1150 mL 0.2301 mL 0.5751 mL

* 备注:如您选择水作为储备液,请稀释至工作液后,再用 0.22 μm 的滤膜过滤除菌后使用。

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Cyclic-di-GMP diammonium
目录号:
HY-107780B
需求量: